U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Search AHRQ

For an exact phrase match, enclose search terms in double quotes.

Go to Advanced Search
Go to Basic Search

Results

Total Results: 543 records

Showing results for "anticoagulant prophylaxis".

  1. Stroke Prevention in Atrial Fibrillation Patients: A Systematic Review Update | Effective Health Care (EHC) Program

    effectivehealthcare.ahrq.gov/products/stroke-afib-update/research-protocol
    July 07, 2017 - Newer anticoagulants (direct oral anticoagulants [DOACs]) resulted in reduced stroke and bleeding events … Procedural interventions Procedural interventions for stroke prophylaxis have emerged and are growing … with AF are uncertain There is a lack of information to guide decisions regarding the best specific anticoagulant … Oral Anticoagulant Prescription in Patients With Atrial Fibrillation and a Low Risk of Thromboembolism … pradaxa[tiab] OR heparin[tiab] OR apixaban[tiab] OR eliquis[tiab] OR edoxaban[tiab] OR lixiana[tiab] OR anticoagulant

  2. Vte-Prophyalaxis Executive (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/vte-prophyalaxis_executive.pdf
    May 01, 2013 - Similarly, we included antiplatelet agents aspirin and clopidogrel; as well as the anticoagulant warfarin … We also included dabigatran, a recently approved oral anticoagulant that directly inhibits thrombin … A study of extended prophylaxis versus inpatient prophylaxis suggested that continuing enoxaparin therapy … Rare events such as bleeding from prophylactic doses of anticoagulant are difficult to answer in trials … Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College

  3. Vte-Prophyalaxis Executive (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/vte-prophyalaxis_executive.pdf
    May 01, 2013 - Similarly, we included antiplatelet agents aspirin and clopidogrel; as well as the anticoagulant warfarin … We also included dabigatran, a recently approved oral anticoagulant that directly inhibits thrombin … A study of extended prophylaxis versus inpatient prophylaxis suggested that continuing enoxaparin therapy … Rare events such as bleeding from prophylactic doses of anticoagulant are difficult to answer in trials … Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College

  4. Agency for Healthcare Research and Quality

    ahrqpubs.ahrq.gov/research/findings/studies/index.html?page=4
    January 01, 2024 - did not reduce clinically important medication errors for ambulatory patients initiating direct oral anticoagulants … The primary measure was anticoagulant-related CIMEs and non-anticoagulant-related CIMEs over 90 days … There was no reduction in anticoagulant-related CIMEs among intervention patients or non-anticoagulant-related … did not reduce clinically important medication errors for ambulatory patients initiating direct oral anticoagulants … Preexposure prophylaxis to prevent acquisition of HIV. Am Fam Physician 2023 Dec; 108(6):617-18..

  5. Agency for Healthcare Research and Quality

    healthcare411.ahrq.gov/research/findings/studies/index.html?page=4
    January 01, 2024 - did not reduce clinically important medication errors for ambulatory patients initiating direct oral anticoagulants … The primary measure was anticoagulant-related CIMEs and non-anticoagulant-related CIMEs over 90 days … There was no reduction in anticoagulant-related CIMEs among intervention patients or non-anticoagulant-related … did not reduce clinically important medication errors for ambulatory patients initiating direct oral anticoagulants … Preexposure prophylaxis to prevent acquisition of HIV. Am Fam Physician 2023 Dec; 108(6):617-18..

  6. Agency for Healthcare Research and Quality

    cahps.ahrq.gov/research/findings/studies/index.html?page=4
    January 01, 2024 - did not reduce clinically important medication errors for ambulatory patients initiating direct oral anticoagulants … The primary measure was anticoagulant-related CIMEs and non-anticoagulant-related CIMEs over 90 days … There was no reduction in anticoagulant-related CIMEs among intervention patients or non-anticoagulant-related … did not reduce clinically important medication errors for ambulatory patients initiating direct oral anticoagulants … Preexposure prophylaxis to prevent acquisition of HIV. Am Fam Physician 2023 Dec; 108(6):617-18..

  7. Agency for Healthcare Research and Quality

    monahrq.ahrq.gov/research/findings/studies/index.html?page=4
    January 01, 2024 - did not reduce clinically important medication errors for ambulatory patients initiating direct oral anticoagulants … The primary measure was anticoagulant-related CIMEs and non-anticoagulant-related CIMEs over 90 days … There was no reduction in anticoagulant-related CIMEs among intervention patients or non-anticoagulant-related … did not reduce clinically important medication errors for ambulatory patients initiating direct oral anticoagulants … Preexposure prophylaxis to prevent acquisition of HIV. Am Fam Physician 2023 Dec; 108(6):617-18..

  8. Agency for Healthcare Research and Quality

    patientregistry.ahrq.gov/research/findings/studies/index.html?page=4
    January 01, 2024 - did not reduce clinically important medication errors for ambulatory patients initiating direct oral anticoagulants … The primary measure was anticoagulant-related CIMEs and non-anticoagulant-related CIMEs over 90 days … There was no reduction in anticoagulant-related CIMEs among intervention patients or non-anticoagulant-related … did not reduce clinically important medication errors for ambulatory patients initiating direct oral anticoagulants … Preexposure prophylaxis to prevent acquisition of HIV. Am Fam Physician 2023 Dec; 108(6):617-18..

  9. Agency for Healthcare Research and Quality

    talkingquality.ahrq.gov/research/findings/studies/index.html?page=4
    January 01, 2024 - did not reduce clinically important medication errors for ambulatory patients initiating direct oral anticoagulants … The primary measure was anticoagulant-related CIMEs and non-anticoagulant-related CIMEs over 90 days … There was no reduction in anticoagulant-related CIMEs among intervention patients or non-anticoagulant-related … did not reduce clinically important medication errors for ambulatory patients initiating direct oral anticoagulants … Preexposure prophylaxis to prevent acquisition of HIV. Am Fam Physician 2023 Dec; 108(6):617-18..

  10. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/866995/psn-pdf
    October 30, 2024 - their response to unfractionated heparin—with some patients requiring large doses to achieve adequate prophylaxis … or activated factor X levels, has been proposed as a means to monitor the effectiveness of heparin prophylaxis … injured patients, ordering clinicians must carefully weigh the risks and benefits of pharmacologic prophylaxis … Early pharmacological venous thromboembolism prophylaxis is safe after operative fixation of traumatic

  11. Stroke Prevention in Atr ial Fibr illation Patients: A Systematic Review (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/stroke-afib-update_research-protocol-amended.pdf
    October 27, 2017 - Newer anticoagulants (direct oral anticoagulants [DOACs]) resulted in reduced stroke and bleeding events … of studies have examined the appropriate populations and appropriate therapies for adequate stroke prophylaxis … Procedural interventions Procedural interventions for stroke prophylaxis have emerged and are growing … AF are uncertain • There is a lack of information to guide decisions regarding the best specific anticoagulant … Oral Anticoagulant Prescription in Patients With Atrial Fibrillation and a Low Risk of Thromboembolism

  12. Stroke Prevention in Atr ial Fibr illation Patients: A Systematic Review (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/stroke-afib-update_research-protocol-amended.pdf
    October 27, 2017 - Newer anticoagulants (direct oral anticoagulants [DOACs]) resulted in reduced stroke and bleeding events … of studies have examined the appropriate populations and appropriate therapies for adequate stroke prophylaxis … Procedural interventions Procedural interventions for stroke prophylaxis have emerged and are growing … AF are uncertain • There is a lack of information to guide decisions regarding the best specific anticoagulant … Oral Anticoagulant Prescription in Patients With Atrial Fibrillation and a Low Risk of Thromboembolism

  13. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/49656/psn-pdf
    June 01, 2012 - Who is responsible for routine patient safety measures, such as deep venous thrombosis prophylaxis? … Because of the risk of central nervous system bleeding, anticoagulant use is a shared responsibility—hospitalists … always contact neurosurgery physicians before starting antiplatelet or anticoagulant agents.

  14. New Mexico Hospitals Use AHRQ Toolkit to Revise Protocol for Preventing Blood Clots | Agency for Healthcare Research and Quality

    ce.effectivehealthcare.ahrq.gov/news/newsroom/case-studies/ktcquips98.html
    October 01, 2014 - As a result, prevalence of appropriate VTE prophylaxis increased from 55 to 100 percent for surgical … prophylaxis and 100 percent for patients admitted to the hospitalist service between March and August … As a result of these interventions, appropriate VTE prophylaxis increased from 0 to 100 percent, and … The dashboard appears in green if the patient is on pharmacological prophylaxis, in yellow if the patient … is on sequential compression devices or if a contraindication is documented, and in red if VTE prophylaxis

  15. A clinical decision support system for prevention of venous thromboembolism: effect on physician behavior | AHRQ Digital Healthcare Research: Informing Improvement in Care Quality, Safety, and Efficiency

    digital.ahrq.gov/health-it-tools-and-resources/health-it-costs-and-benefits-database/clinical-decision-support-system
    June 07, 2000 - Purpose of Study:  Determine whether presentation of venous thromboembolism prophylaxis guidelines using

  16. Carbohydrates | Effective Health Care (EHC) Program

    effectivehealthcare-admin.ahrq.gov/health-topics/carbohydrates?page=1
    May 29, 2013 - Products Systematic Review Archived May 29, 2013 Pharmacologic and Mechanical Prophylaxis … difficile Infection Systematic Review Archived March 13, 2012 Venous Thromboembolism Prophylaxis … Protocol Archived January 12, 2012 Comparative Effectiveness of Pharmacologic and Mechanical Prophylaxis … Protocol Archived August 6, 2010 Comparative Effectiveness of Venous Thromboembolism (VTE) Prophylaxis

  17. Automatic detection of omissions in medication lists. | PSNet

    psnet.ahrq.gov/issue/automatic-detection-omissions-medication-lists
    December 31, 2014 - December 7, 2011 Modes of failure in venous thromboembolism prophylaxis. … December 16, 2020 WebM&M Cases Direct Oral Anticoagulants

  18. Auditing Your Briefings and Debriefings Process: Slide Presentation | Agency for Healthcare Research and Quality

    pbrn.ahrq.gov/hai/tools/surgery/modules/implementation/audit-briefing-slides.html
    December 01, 2017 - Bleeding concerns (e.g., anticoagulant use). Blood availability. Allergies. … Deep vein thrombosis prophylaxis. Warmers. Lab/radiology review. … Deep vein thrombosis (DVT) prophylaxis  - 100% Yes. Glycemic control - 40% Yes. … Anticoagulant use - 10% Yes. Access issues - 20% Yes. Airway risk - 20% Yes.

  19. Auditing Your Briefings and Debriefings Process: Slide Presentation | Agency for Healthcare Research and Quality

    pcmh.ahrq.gov/hai/tools/surgery/modules/implementation/audit-briefing-slides.html
    December 01, 2017 - Bleeding concerns (e.g., anticoagulant use). Blood availability. Allergies. … Deep vein thrombosis prophylaxis. Warmers. Lab/radiology review. … Deep vein thrombosis (DVT) prophylaxis  - 100% Yes. Glycemic control - 40% Yes. … Anticoagulant use - 10% Yes. Access issues - 20% Yes. Airway risk - 20% Yes.

  20. Final Progress Report: Patient-centered approach to reducing harm from VTE (pdf file)

    www.ahrq.gov/sites/default/files/2024-07/rothberg-report.pdf
    January 01, 2024 - rate of prophylaxis is high but the rate of inappropriate prophylaxis is also high. … Patients received enoxaparin 40 mg/day for prophylaxis. … any prophylaxis, adjusted for baseline risk of VTE. … In the base case, prophylaxis had an incremental cost of $44,091/QALY saved compared with no prophylaxis … An observational study of the effectiveness of VTE prophylaxis, comparing patients who received prophylaxis
SHARE:
Facebook Twitter Print Facebook Share

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

Click to show only results for the selected site.

www.ahrq.gov (106)

psnet.ahrq.gov (62)

cmext.ahrq.gov (60)

effectivehealthcare-admin.ahrq.gov (59)

ce.effectivehealthcare.ahrq.gov (53)

effectivehealthcare.ahrq.gov (46)

www.uspreventiveservicestaskforce.org (20)

www.qualitymeasures.ahrq.gov (17)

digital.ahrq.gov (10)

pbrn.ahrq.gov (8)

pcmh.ahrq.gov (8)

www.cpsi.ahrq.gov (8)

ahrqpubs.ahrq.gov (7)

cahps.ahrq.gov (7)

healthcare411.ahrq.gov (7)

monahrq.ahrq.gov (7)

patientregistry.ahrq.gov (7)

qualityindicators.ahrq.gov (6)

talkingquality.ahrq.gov (6)

www.cahps.ahrq.gov (6)

preventiveservices.ahrq.gov (5)

teamstepps.ahrq.gov (5)

www.healthcare411.ahrq.gov (5)

www.innovations.ahrq.gov (5)

www.monahrq.ahrq.gov (5)

www.talkingquality.ahrq.gov (5)

cds.ahrq.gov (3)